Advanced search    

Search: authors:"Santiago Zuluaga-Sanchez"

3 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Cost Effectiveness of Nusinersen in the Treatment of Patients with Infantile-Onset and Later-Onset Spinal Muscular Atrophy in Sweden

models. Santiago Zuluaga Sanchez developed the cost-effectiveness models and executed all analyses. Santiago Zuluaga Sanchez led the interpretation of findings together with Christopher Knight, Thomas ... Lundqvist, Mats Ekelund and Annabelle Forsmark with input from the other authors. Santiago Zuluaga Sanchez and Annabelle Forsmark drafted the manuscript. All authors reviewed the manuscript and approved the

Cost-Effectiveness of Olaratumab in Combination with Doxorubicin for Patients with Soft Tissue Sarcoma in the United States

29 November 2017; Published 26 March 2018 Academic Editor: Valerae O. Lewis Copyright © 2018 Santiago Zuluaga-Sanchez et al. This is an open access article distributed under the Creative Commons ... a poster at the 22nd Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research in Boston, MA (May 20–24, 2017). Conflicts of Interest Santiago Zuluaga-Sanchez, Sorrel E

Cost-Effectiveness of Olaratumab in Combination with Doxorubicin for Patients with Soft Tissue Sarcoma in the United States

29 November 2017; Published 26 March 2018 Academic Editor: Valerae O. Lewis Copyright © 2018 Santiago Zuluaga-Sanchez et al. This is an open access article distributed under the Creative Commons ... a poster at the 22nd Annual Meeting of the International Society for Pharmacoeconomics and Outcomes Research in Boston, MA (May 20–24, 2017). Conflicts of Interest Santiago Zuluaga-Sanchez, Sorrel E